在日常实践中符合COAPT试验的资格:现实世界的经验
Edoardo Zancanaro1, Nicola Buzzatti1, Paolo Denti1
1Department of Cardiac Surgery, San Raffaele Scientific Institute, Milan, Italy.
概括
只有14%的功能性额头肌吐 (FMR) 患者满足了COAPT试验的标准. 然而,MitraClip治疗改善了非COAPT符合条件的患者的生存率,这表明过导管美肌修复的应用范围更广.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏门疾病 心脏门疾病
背景情况:
- 在COAPT试验中,在选择的功能性额头吐 (FMR) 患者中,通过导管额头修复的生存益处被确定.
- 在现实世界中,COAPT选择标准的适用性仍然不清楚.
研究的目的:
- 在现实环境中评估符合COAPT标准的FMR患者的比例.
- 评估COAPT标准对患者生存结果的影响.
主要方法:
- 在第三级医院对连续的FMR患者 (2016年1月至2021年5月) 的回顾性分析.
- 由心脏外科医生和心脏病学家对COAPT资格的评估.
- 在接受MitraClip的患者和接受优化医疗治疗的患者之间生存率的比较.
主要成果:
- 在转诊的FMR患者中,只有14% (56名394名) 符合COAPT资格标准.
- 常见的排除原因包括轻度/中度反,异常的喷射分数和非优化的指导方针导向医学治疗.
- 在非COAPT符合条件的患者中,那些接受MitraClip治疗的人与单独优化医疗治疗 (71.8%) 相比,显示了显著更高的加权4年生存率 (91.5%).
结论:
- 一小部分现实 FMR 患者符合严格的 COAPT 试验选择标准.
- 通过MitraClip进行过导管美特拉修复,即使在不符合COAPT标准的FMR患者中,也可能带来生存益处,这表明治疗潜力扩大.
更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.6K
06:13Author Spotlight: Insights into Remotely Supervised Neuromodulation Procedure for Phantom Limb Pain
Published on: March 1, 2024
895
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
